Jpm Partners Llc - Net Worth and Insider Trading

Jpm Partners Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jpm Partners Llc owns 1 companies in total, including Atea Pharmaceuticals Inc (AVIR) .

Click here to see the complete history of Jpm Partners Llc’s form 4 insider trades.

Insider Ownership Summary of Jpm Partners Llc

Ticker	Comapny	Transaction Date	Type of Owner
AVIR	Atea Pharmaceuticals Inc	2020-10-29	10 percent owner

Jpm Partners Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jpm Partners Llc Ownership Network

Ownership Network List of Jpm Partners Llc

No Data

Ownership Network Relation of Jpm Partners Llc

Jpm Partners Llc Owned Company Details

What does Atea Pharmaceuticals Inc do?

Who are the key executives at Atea Pharmaceuticals Inc?

Jpm Partners Llc is the 10 percent owner of Atea Pharmaceuticals Inc. Other key executives at Atea Pharmaceuticals Inc include director & 10 percent owner & President & CEO & and Chairman Jean-pierre Sommadossi , See Remarks Andrea Corcoran , and See Remarks Wayne Foster .

Atea Pharmaceuticals Inc (AVIR) Insider Trades Summary

Over the past 18 months, Jpm Partners Llc made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 115,885 shares made by Jean-pierre Sommadossi , a net sale of 17,544 shares made by Bruce Polsky , and a net sale of 15,870 shares made by Maria Arantxa Horga .

In summary, during the past 3 months, insiders sold 57,969 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 57,969 shares. During the past 18 months, 203,467 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,467 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Atea Pharmaceuticals Inc Insider Transactions

No Available Data

Jpm Partners Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Jpm Partners Llc. You might contact Jpm Partners Llc via mailing address: C/o Atea Pharmaceuticals, Inc., 125 Summer Street, Boston Ma 02110.

Discussions on Jpm Partners Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.